Novartis/NVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Ticker
NVS
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
Headquarters
Basel, Switzerland
Employees
76,057
Website
www.novartis.com
Novartis Metrics
BasicAdvanced
$226B
Market cap
13.99
P/E ratio
$7.37
EPS
0.58
Beta
$3.50
Dividend rate
3.63%
Dividend yield
Price and volume
Market cap
$226B
Beta
0.58
52-week high
$108.78
52-week low
$88.86
Average daily volume
31
Dividend rate
$3.50
Financial strength
Current ratio
0.903
Quick ratio
0.707
Long term debt to equity
47.183
Total debt to equity
68.547
Dividend payout ratio (TTM)
77.34%
Enterprise value to free cash flow
27.828
Interest coverage (TTM)
13.88%
Management effectiveness
Return on assets (TTM)
8.82%
Return on equity (TTM)
19.86%
Return on investment (TTM)
12.43%
Valuation
Price to earnings (TTM)
13.989
Price to revenue (TTM)
4.739
Price to book
5.086
Price to free cash flow (TTM)
44.185
Five year average dividend yield
3.55%
Dividend yield (TTM)
3.39%
Forward dividend yield
3.63%
Growth
Revenue change (TTM)
14.72%
Earnings per share change (TTM)
58.09%
3-year revenue growth
-2.21%
3-year earnings per share growth
5.22%
3-year dividend per share growth
4.26%
What the Analysts think about Novartis
Analyst Ratings
Majority rating from 11 analysts.
Novartis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$12B
2.92%
Net income
$2.7B
-68.30%
Profit margin
22.17%
-69.21%
Novartis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.83
$1.83
$1.53
$1.80
-
Expected
$1.68
$1.70
$1.69
$1.69
$1.86
Surprise
8.68%
7.86%
-9.20%
6.76%
-
Novartis News
AllArticlesVideos
Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
Business Wire·2 months ago
10 Sleep-Well-At-Night Dividend Aristocrats Perfect For Whatever's Coming Next
Seeking Alpha·2 months ago
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractionalADR
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novartis stock?
Novartis (NVS) has a market cap of $226B as of July 03, 2024.
What is the P/E ratio for Novartis stock?
The price to earnings (P/E) ratio for Novartis (NVS) stock is 13.99 as of July 03, 2024.
Does Novartis stock pay dividends?
Yes, the Novartis (NVS) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $3.4987 and the yield is 3.63%. Novartis has a payout ratio of 77.34% on a trailing twelve-month basis.
When is the next Novartis dividend payment date?
The next Novartis (NVS) dividend payment date is unconfirmed.
What is the beta indicator for Novartis?
Novartis (NVS) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Novartis stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.